Topiramat-Mepha Teva

Topiramat-Mepha Teva Uses, Dosage, Side Effects, Food Interaction and all others data.

Topiramat-Mepha Teva is a sulfamate-substituted monosaccharide, related to fructose. Topiramat-Mepha Teva is quickly absorbed after oral use. Topiramat-Mepha Teva enhances GABA-activated chloride channels. In addition, topiramate inhibits excitatory neurotransmission, through actions on kainate and AMPA receptors. Topiramat-Mepha Teva has a specific effect on GluR5 kainate receptors. It is also an inhibitor of carbonic anhydrase, particularly subtypes II and IV, but this action is weak and unlikely to be related to its anticonvulsant actions, but may account for the bad taste and the development of renal stones seen during treatment. Its possible effect as a mood stabilizer seems to occur before anticonvulsant qualities at lower dosages.

Topiramat-Mepha Teva prevents the occurrence of seizures and prevents migraine symptoms by reducing neural pathway excitability. It is important to note that this drug may cause metabolic acidosis, mood changes, suicidal thoughts and attempts, as well as kidney stones. When topiramate is combined with valproic acid, it is known to cause hypothermia.

Trade Name Topiramat-Mepha Teva
Availability Prescription only
Generic Topiramate
Topiramate Other Names Tipiramate, Tipiramato, Topiramate, Topiramato, Topiramatum
Related Drugs Emgality, Trokendi XR, Reyvow, gabapentin, propranolol, clonazepam, lamotrigine, diazepam, atenolol, pregabalin
Type
Formula C12H21NO8S
Weight Average: 339.362
Monoisotopic: 339.098787343
Protein binding

Topiramate is not highly bound to plasma proteins, with an estimated plasma protein binding of 9-17% according to some studies. The FDA label indicates that the protein binding of topiramate is 15-41%.

Groups Approved
Therapeutic Class Adjunct anti-epileptic drugs
Manufacturer
Available Country Switzerland
Last Updated: September 19, 2023 at 7:00 am
Topiramat-Mepha Teva
Topiramat-Mepha Teva

Uses

This drug is used to treat epilepsy in both children and adults. In children it is also used for treatment of Lennox-Gastaut syndrome (a disorder that causes seizures and developmental delay). It is now most frequently prescribed for the prevention of migraines. It has been used by psychiatrists to treat bipolar disorder and alcoholism.

The drug is also used to treat Post Traumatic Stress Disorder. Studies suggest that Topiramat-Mepha Teva is effective against infantile spasms.

Monotherapy in Epilepsy: Topiramat-Mepha Teva is used for initial monotherapy in patients of 10 years of age and older with partial onset or primary generalized tonic-clonic seizures.

Adjunctive Therapyin Epilepsy: Topiramat-Mepha Teva is used for adjunctive therapy for adults and pediatric patients ages 2-16 years with partial onset seizures, or primary generalized tonic-clonic seizures, and in patients 2 years of age and older with seizures associated with Lennox-Gastaut syndrome.

Migraine: Topiramat-Mepha Teva is used for adults for the prophylaxis of migraine headache.

Topiramat-Mepha Teva is also used to associated treatment for these conditions: Alcohol Dependency, Grand mal Generalized tonic-clonic seizure, Lennox-Gastaut Syndrome (LGS), Migraine, Moods Disorders, Partial-Onset Seizures, Weight, Primary generalized tonic-clonic seizure Epilepsy, Weight Reduction

How Topiramat-Mepha Teva works

A seizure is an abnormal and unregulated electrical discharge occurring in the brain. This leads to transient interruption in brain function, manifested by reduced alertness, abnormal sensations, and focal involuntary movements or convulsions. Several types of seizures exist, with common types including tonic-clonic seizures and partial onset seizures.

The exact mechanisms by which topiramate exerts pharmacological actions on seizures and migraines are currently not fully characterized. Several properties of this drug, however, are likely to contribute to its therapeutic effects. Topiramat-Mepha Teva has been observed to exert actions on voltage-dependent sodium channels, GABA receptors, and glutamate receptors.

Topiramat-Mepha Teva stimulates GABA-A receptor activity at brain non-benzodiazepine receptor sites and reduces glutamate activity at both AMPA and kainate receptors. Normally, GABA-A receptors are inhibitory and glutaminergic receptors are stimulatory for neuronal activity. By increasing GABA activity and inhibiting glutamate activity, topiramate blocks neuronal excitability, preventing seizures and migraines. Additionally, it blocks the voltage-dependent sodium channels, further blocking seizure activity. Topiramat-Mepha Teva has been shown to inhibit various carbonic anhydrase isozymes, but the clinical significance of this is unknown at this time.

Dosage

Topiramat-Mepha Teva dosage

The initial dose normally is low and increased in slow steps.The usual initial dose is 25 to 50 mg daily in 2 single doses. Recommended increments are 25 to 50 mg every 1 or 2 weeks. Common doses for maintenance treatment are 100 to 200 mg daily. The highest dose possible is 1,000 mg daily in divided doses.

Monotherapy Use: The recommended maximum dose for Topiramat-Mepha Teva monotherapy in adults and children 10 years of age and older is 400 mg/day in two divided doses.

Adjunctive Therapy Use Adults (17 Years of Age and Over): The recommended total daily dose of Topiramat-Mepha Teva is 400 mg/day in Partial Seizures or Primary Generalized Tonic-Clonic Seizures. Daily doses above 1600 mg have not been studied.

Pediatric Patients (Ages 2 to 16 Years): Partial Seizures or Primary Generalized Tonic-Clonic Seizures The recommended total daily dose of Topiramat-Mepha Teva tablets as adjunctive therapy for patients with partial seizures or primary generalized tonic-clonic seizures is approximately 5 to 9 mg/kg/day in two divided doses.Titration should begin at 25 mg (or less, based on a range of 1 to 3 mg/kg/day) nightly for the first week. The dosage should then be increased at 1 or 2 week intervals by increments of 1 to 3 mg/kg/day (administered in two divided doses), to achieve optimal clinical response. Dose titration should be guided by clinical outcome.

Topiramat-Mepha Teva tablets can be taken without regards to meals.

Side Effects

The most common side effects include a change in taste and feelings of pins and needles in the head and extremities. Less common side effects include cognitive deficiency (particularly word-finding difficulty); difficulty in understanding, grogginess, lethargy, renal (kidney) stones, vision abnormality, weight loss, breast pain, abdominal pain, intense sweating, menstrual disorder and dry mouth.

Toxicity

The LD50 of intraperitoneal topiramate in the rat is above 1500 mg/kg.

Overdose information

In a study of 4 healthy adult women taking topiramate, the severity of clinical effects following an overdose ranged from asymptomatic to severe, with no deaths reported. According to the FDA prescribing information for topiramate, an overdose may cause hypotension, severe metabolic acidosis, coma, abdominal pain, visual disturbances, convulsions, drowsiness, speech abnormalities, impaired mentation and coordination, stupor, agitation, dizziness, as well as depression.

In the case of a recent ingestion of topiramate, the stomach contents should be emptied through the induction of emesis or gastric lavage. Offer supportive treatment, including activated charcoal and hemodialysis.

Precaution

Concomitant administration of Topiramat-Mepha Teva and valproic acid has been associated with hyperammonemia with or without encephalopathy in patients who have tolerated either drug alone. In patients who develop unexplained lethargy, vomiting, or changes in mental status, hyperammonemic encephalopathy should be considered and an ammonia level should be measured.

Interaction

Potential interactions between Topiramat-Mepha Teva and standard AEDs like Phenytoin, Carbamazepine and Valproic acid were observed during the concomitant treatment with these drugs for antiepileptic patients. Beside these. Concomitant use of Topiramat-Mepha Teva, a carbonic anhydrase inhibitor, with other carbonic anhydrase inhibitors, e.g., acetazolamide or dichlorphenamide, may create a physiological environment that increases the risk of renal stone formation. Digoxin, CNS depressants, oral contraceptives. Hydrochlorothiazide (HCTZ) may also interact with Topiramat-Mepha Teva.

Food Interaction

  • Avoid a ketogenic diet. This type of diet increases the risk of kidney stones.
  • Take with or without food. Food slightly alters absorption but not to any clinically significant extent.

Topiramat-Mepha Teva Alcohol interaction

[Moderate] GENERALLY AVOID:

Topiramat-Mepha Teva, when coadministered with other CNS depressants including alcoholic beverages, may lead to excessive somnolence and other forms of nervous system depression.



The patient should be informed to avoid alcohol or to use caution if these agents are coadministered, especially if performing hazardous tasks such as driving or operating machinery.

Volume of Distribution

The mean apparent volume of distribution of topiramate ranges from 0.6-0.8 L/kg when doses of 100mg to 1200mg are given. Topiramat-Mepha Teva readily crosses the blood-brain barrier.

Elimination Route

After a 400mg dose in one clinical trial, topiramate reached maximal concentrations within 1.8-4.3 hours and ranged from 1.73-28.7 ug/mL. Food did not significantly affect the extent of absorption, despite delaying time to peak concentration. In patients with normal creatinine clearance, steady state concentrations are reached within 4 days. The bioavailability of topiramate in tablet form is about 80% compared to a topiramate solution.

Half Life

The elimination half-life is reported to be in the range of 19-23 hours. If topiramate is given with enzyme-inducers, the half-life can be reduced to 12-15 hours because of increased metabolism.

Clearance

The mean oral plasma clearance of topiramate ranges from 22-36 mL/min while the renal clearance is 17-18 mL/min, according to one pharmacokinetic study. The FDA label for topiramate indicates a similar oral plasma clearance of approximately 20 to 30 mL/min in adults.

Elimination Route

Topiramat-Mepha Teva is mainly eliminated through the kidneys. About 70-80% of the eliminated dose is found unchanged in the urine.

Pregnancy & Breastfeeding use

Topiramat-Mepha Teva is pregnancy category C. So it may be given only if clearly needed and after the assessment of risk benefit ratio. It is not known whether Topiramat-Mepha Teva is excreted through breast milk. So caution should be taken if it is prescribed to a breast feeding mother.

Contraindication

Topiramat-Mepha Teva tablets are contraindicated in patients with a history of hypersensitivity to any component of this product.

Special Warning

Patients with Renal Impairment: In renally impaired subjects (creatinine clearance less than 70 ml/min/1.73 m2), one-half of the usual adult dose is recommended. Such patients will require a longer time to reach steady-state at each dose.

Patients Undergoing Hemodialysis: Topiramat-Mepha Teva is cleared by hemodialysis at a rate that is 4 to 6 times greater than a normal individual. Accordingly, a prolonged period of dialysis may cause Topiramat-Mepha Teva concentration to fall below that required to maintain an anti-seizure effect.To avoid rapid drops in Topiramat-Mepha Teva plasma concentration during hemodialysis, a supplemental dose of Topiramat-Mepha Teva may be required. The actual adjustment should take into account 1) the duration of dialysis period, 2) the clearance rate of the dialysis system being used, and 3) the effective renal clearance of Topiramat-Mepha Teva in the patient being dialyzed.

Acute Overdose

Overdoses of Topiramat-Mepha Teva includes convulsions, drowsiness, speech disturbance, blurred vision, diplopia, lethargy, abnormal coordination, stupor, hypotension, abdominal pain, agitation, dizziness and depression.The clinical consequences are not severe. Topiramat-Mepha Teva overdose results in severe metabolic acidosis.

In acute Topiramat-Mepha Teva overdose, if the ingestion is recent, the stomach should be emptied immediately by lavage or by induction of ernes is. Activated charcoal has been shown to adsorb Topiramat-Mepha Teva in vitro. Hemodialysis is an effective means of removing Topiramat-Mepha Teva from the body.

Storage Condition

Store at a cool & dry place, protected from light and moisture. Keep out of reach of the children.

Innovators Monograph

You find simplified version here Topiramat-Mepha Teva

Topiramat-Mepha Teva contains Topiramate see full prescribing information from innovator Topiramat-Mepha Teva Monograph, Topiramat-Mepha Teva MSDS, Topiramat-Mepha Teva FDA label

FAQ

What is Topiramat-Mepha Teva used for?

Topiramat-Mepha Teva is a medicine used to treat epilepsy. These are also called anti-epileptic medicines. It can also be taken to prevent migraine. This medicine is only available on prescription.

How safe is Topiramat-Mepha Teva?

Topiramat-Mepha Teva is safe for long-term use when taken as prescribed. However, several common and potentially severe side effects have been reported by a small number of patients. There are also quite a few drugs that can cause harmful interactions or become ineffective when taken in conjunction with Topiramat-Mepha Teva.

How does Topiramat-Mepha Teva work?

Topiramat-Mepha Teva works by reducing the spread of seizure activity in the brain and restoring the normal balance of nerve activity.

What are the common side effects of Topiramat-Mepha Teva?

Common side effects of Topiramat-Mepha Teva include feeling sleepy, dizziness, diarrhoea and feeling sick. These are usually mild and go away by themselves.

Is Topiramat-Mepha Teva safe during pregnancy?

If you take Topiramat-Mepha Teva during pregnancy, there is a higher risk that your baby will develop a cleft lip and cleft palate. Oral clefts happen early in pregnancy, before many women even know they are pregnant.

Is Topiramat-Mepha Teva safe during breastfeeding?

Topiramat-Mepha Teva passes into breast milk. Babies usually have very low levels of Topiramat-Mepha Teva in their systems, and side effects or harmful effects in the nursing baby are rarely reported.

Can I drink alcohol with Topiramat-Mepha Teva?

Because Topiramat-Mepha Teva can cause mental and psychological side effects, it's not recommended that you drink alcohol while taking Topiramat-Mepha Teva.

Can I drive after taking Topiramat-Mepha Teva?

Do not drive a car or operate machinery until you know how this medication affects you. if you are taking Topiramat-Mepha Teva to control seizures, you should know that you may continue to have seizures during your treatment.

When is the best time to take Topiramat-Mepha Teva?

You can take Topiramat-Mepha Teva at any time of day, but try to take your doses at the same time each day. Try to space your doses evenly through the day. For example, first thing in the morning and in the evening. Topiramat-Mepha Teva tablets can be taken with or without food.

Is Topiramat-Mepha Teva safe to take long term?

Yes, many people take Topiramat-Mepha Teva safely for many months or years.

What does Topiramat-Mepha Teva do to the brain?

Topiramat-Mepha Teva decrease abnormal excitement in the brain. Among other actions,Topiramat-Mepha Teva affects the activity of the neurotransmitter gamma-aminobutyrate.

Is Topiramat-Mepha Teva good for anxiety?

Topiramat-Mepha Teva isn't approved to treat anxiety. However, the drug may sometimes be used off-label to treat people with certain anxiety disorders, such as obsessive-compulsive disorder.

Should I take Topiramat-Mepha Teva at night or in the morning?

Topiramat-Mepha Teva is usually taken with or without food once a day in the morning. Topiramat-Mepha Teva may cause difficulty falling asleep or staying asleep if it is taken in the evening. Take phentermine and Topiramat-Mepha Teva at around the same time every day.

Can Topiramat-Mepha Teva cause a stroke?

Hypohidrosis is one of the described side effects of Topiramat-Mepha Teva, and it can contribute to the development of heart stroke in patients taking this drug.

Can Topiramat-Mepha Teva cause heart problems?

Topiramat-Mepha Teva can increase your resting heart rate.

How fast will I lose weight on Topiramat-Mepha Teva?

It can take some time to see weight loss results from taking Topiramat-Mepha Teva. Some people may not notice a difference until they've taken the drug for at least four months, while other people may start to lose weight in their first month of taking it. Weight loss results from topiramate are proven to increase over time.

How long does it take Topiramat-Mepha Teva to get out of my system?

Topiramat-Mepha Teva stays in your system between four and six days after your last dose, depending on your personal factors such as dosage and metabolism.

Is Topiramat-Mepha Teva hard on the liver?

Topiramat-Mepha Teva is thought to be rarely associated with liver injury and by and large known to cause liver toxicity in conjunction with other anticonvulsants.

Is Topiramat-Mepha Teva bad for my kidneys?

Topiramat-Mepha Teva can increase the level of acid in your blood . This can weaken your bones, cause kidney stones, or cause growth problems in children .

Does Topiramat-Mepha Teva cause chest pain?

Chest pain is a previously undocumented potential side effect of Topiramat-Mepha Teva.

Is Topiramat-Mepha Teva an anti inflammatory?

Topiramat-Mepha Teva modulates post-infarction inflammation primarily by targeting monocytes or macrophages.

Will Topiramat-Mepha Teva effect my fertility?

Topiramat-Mepha Teva for 4 weeks did not have much effect on fertility.

Can I take Topiramat-Mepha Teva long time ?

Topiramat-Mepha Teva usually takes a couple of weeks for it to work. If taking Topiramat-Mepha Teva to prevent migraines, it can take up to 3 months for it to work fully.

What happen If I stop Topiramat-Mepha Teva suddenly ?

If you suddenly stop taking Topiramat-Mepha Teva, you may have severe seizures, even if you have not had seizures in the past. Your doctor will probably decrease your dose gradually.

What happens if I overdose?

An overdose of topiramate can be fatal.
Overdose can cause drowsiness, agitation, depression, double vision, thinking problems, problems with speech or coordination, fainting, and seizure.

http://classyfire.wishartlab.com/tax_nodes/C0000000
http://classyfire.wishartlab.com/tax_nodes/C0000002
http://classyfire.wishartlab.com/tax_nodes/C0001985
http://classyfire.wishartlab.com/tax_nodes/C0001985
http://classyfire.wishartlab.com/tax_nodes/C0004472
http://classyfire.wishartlab.com/tax_nodes/C0002012
http://classyfire.wishartlab.com/tax_nodes/C0001540
http://classyfire.wishartlab.com/tax_nodes/C0000403
http://classyfire.wishartlab.com/tax_nodes/C0001316
http://classyfire.wishartlab.com/tax_nodes/C0004140
http://classyfire.wishartlab.com/tax_nodes/C0003940
http://classyfire.wishartlab.com/tax_nodes/C0004707
http://classyfire.wishartlab.com/tax_nodes/C0004150
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:63631
http://www.hmdb.ca/metabolites/HMDB0005034
http://www.genome.jp/dbget-bin/www_bget?drug:D00537
http://www.genome.jp/dbget-bin/www_bget?cpd:C07502
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5284627
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46508334
https://www.chemspider.com/Chemical-Structure.4447672.html
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10887
https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=38404
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=63631
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL220492
https://zinc.docking.org/substances/ZINC000095616603
http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP000137
http://www.pharmgkb.org/drug/PA451728
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/TOR
http://www.rxlist.com/cgi/generic2/topiram.htm
https://www.drugs.com/cdi/topiramate.html
http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/top1541.shtml
https://en.wikipedia.org/wiki/Topiramate
*** Taking medicines without doctor's advice can cause long-term problems.
Share